About ReBiotics Labs

Founded by visionary scientists and entrepreneurs, we're dedicated to harnessing the power of biology to solve humanity's greatest challenges.

Our Mission

To accelerate biotechnology innovation through our integrated platform, enabling the development of sustainable solutions that improve human health and environmental well-being.

Our Vision

A world where biotechnology serves as the foundation for sustainable prosperity, where biological solutions address global challenges while preserving our planet for future generations.

Our Story

Founded on Innovation

ReBiotics Labs was founded in 2020 by a team of accomplished scientists and entrepreneurs who recognized the need for a new approach to biotechnology development. Frustrated by the slow pace of traditional research and the barriers between discovery and application, they set out to create an integrated platform that would accelerate innovation.

Our founders brought together decades of experience from leading academic institutions, biotechnology companies, and research organizations. This diverse background enabled the creation of a unique platform that combines cutting-edge research capabilities with practical engineering solutions.

Today, ReBiotics Labs stands at the forefront of biotechnology innovation, with a growing portfolio of successful projects and partnerships spanning healthcare, agriculture, and environmental applications.

Company founding story

Leadership Team

Dr. Emily Harrison

Dr. Emily Harrison

Chief Executive Officer

Former VP of Research at a leading biotech company with 15+ years of experience in therapeutic development and commercialization.

Dr. Michael Chen

Dr. Michael Chen

Chief Scientific Officer

Renowned synthetic biologist with groundbreaking research in metabolic engineering and biosystem design, formerly at MIT.

Sarah Rodriguez

Sarah Rodriguez

Chief Technology Officer

Expert in bioprocess engineering and automation with extensive experience in scaling biotechnology solutions.

Dr. Elvin Prasad

Dr. Elvin Prasad

Chief Operating Officer

Seasoned Tech Executive with proven track record in operations, regulatory affairs, and business development.

Our Values

Scientific Excellence

Commitment to the highest standards of scientific rigor and research integrity in all our work.

Innovation

Pushing the boundaries of what's possible through creative problem-solving and technological advancement.

Collaboration

Believing that the greatest breakthroughs come from diverse perspectives and shared expertise.

Sustainability

Developing solutions that not only solve today's problems but contribute to a sustainable future.

Ethical Leadership

Maintaining the highest ethical standards and responsible innovation practices in all our activities.

Global Impact

Striving to make biotechnology accessible and beneficial to communities worldwide.

Key Achievements

2025

Global Expansion

Opened research facilities in Europe and Asia, establishing ReBiotics Labs as a truly global biotechnology platform.

2024

Major Partnerships

Established strategic partnerships with three Fortune 500 companies and five leading academic institutions.

2023

Technology Breakthrough

Developed proprietary AI-driven protein design platform, reducing development time by 70%.

2022

Series A Funding

Completed $50M Series A funding round led by prominent biotech venture capital firms.

2021

First Commercial Success

Successfully brought first therapeutic protein from discovery to market in record time.

2020

Company Founded

ReBiotics Labs founded with the vision of revolutionizing biotechnology development.